IL-33 released by alum is responsible for early cytokine production and has adjuvant properties

por Rose II, William A., Okragly, Angela J., Patel, Chetan N., Benschop, Robert J.
Publicado 2015

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab

por Okragly, Angela J., Ryuzoji, Aya, Wulur, Isabella, Daniels, Montanea, Van Horn, Robert D., Patel, Chetan N., Benschop, Robert J.
Publicado 2023

Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis

por JU, Teresa, LABIB, Angelina, NATTKEMPER, Leigh, ENGLE, Sarah, AUXIER, Autum, HAHN, Nathan, SISSONS, Sean, SIMS, Jonathan T., SUN, Zhe, OKRAGLY, Angela J., YOSIPOVITCH, Gil
Publicado 2023

Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production

por Rose, William A., Okragly, Angela J., Hu, Ningjie N., Daniels, Montanea R., Martin, Andrea P., Koh, Yi Ting, Kikly, Kristine, Benschop, Robert J.
Publicado 2018

Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis

por Parthasarathy, Varsha, Cravero, Karen, Deng, Junwen, Sun, Zhe, Engle, Sarah M., Auxier, Autum N., Hahn, Nathan, Sims, Jonathan T., Okragly, Angela J., Alphonse, Martin P., Kwatra, Shawn G.
Publicado 2022

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33

por Okragly, Angela J, Corwin, Katie Brannon, Elia, Marikka, He, Dongmei, Schroeder, Oliver, Zhang, Qing, Shiyanova, Tatiyana, Bright, Stuart, Dicker, Sarah B, Chlewicki, Lukasz, Truhlar, Stephanie M E, Davies, Julian, Patel, Chetan N, Benschop, Robert J
Publicado 2021